Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
There is consistent, unequivocal and reproducible epidemiological evidence derived from diverse populations that various indices of glycemia (fasting plasma glucose, post-prandial or post oral glucose challenge plasma glucose, HbA1c) are associated with an increased risk of atherosclerotic cardiovas...
Main Authors: | Avital Nahmias, Priska Stahel, Changting Xiao, Gary F. Lewis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2020.00100/full |
Similar Items
-
Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes Mellitus
by: Thomas M. MacDonald, et al.
Published: (2018-09-01) -
Relevance of results of the ADVANCE study for diabetes control in Russia
by: Ivan Ivanovich Dedov, et al.
Published: (2009-06-01) -
Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study
by: Xuelin Yao, et al.
Published: (2023-05-01) -
Causes behind the failure to manage patients with type 2 diabetes mellitus. The role of postprandial glycemia
by: Elena Valer'evna Doskina
Published: (2010-03-01) -
Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus
by: A S Ametov, et al.
Published: (2010-08-01)